BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 24434363)

  • 1. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, epidemiology and treatment of inflammatory neuropathies.
    Baig F; Knopp M; Rajabally YA
    Br J Hosp Med (Lond); 2012 Jul; 73(7):380-5. PubMed ID: 22875431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune-mediated neuropathies].
    Stoll G; Reiners K
    Nervenarzt; 2016 Aug; 87(8):887-98. PubMed ID: 27474733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune-mediated neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 2009 Nov; 49(11):956-8. PubMed ID: 20030259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated neuropathies.
    Kieseier BC; Mathey EK; Sommer C; Hartung HP
    Nat Rev Dis Primers; 2018 Oct; 4(1):31. PubMed ID: 30310069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in immune-mediated inflammatory neuropathies.
    Martín-Aguilar L; Pascual-Goñi E; Querol L
    Med Clin (Barc); 2019 Nov; 153(9):360-367. PubMed ID: 31443948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies.
    Collet R; Caballero-Ávila M; Querol L
    Rev Neurol (Paris); 2023 Oct; 179(8):831-843. PubMed ID: 36907709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-Mediated Neuropathies.
    Gwathmey KG; Smith AG
    Neurol Clin; 2020 Aug; 38(3):711-735. PubMed ID: 32703478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.
    Mathis S; Vallat JM; Magy L
    Immunotherapy; 2016 Feb; 8(2):165-78. PubMed ID: 26809024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory neuropathies.
    Whitesell J
    Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances and perspectives in treatment for refractory neuropathies with special reference to immune-mediated neuropathies and Crow-Fukase syndrome].
    Kuwabara S
    Rinsho Shinkeigaku; 2010 Apr; 50(4):219-24. PubMed ID: 20411803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune neuropathies.
    Bertorini T; Narayanaswami P
    Compr Ther; 2003; 29(4):194-209. PubMed ID: 14989041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ; Kuntzer T; Steck AJ
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deterioration after Guillain-Barré syndrome: recurrence, treatment-related fluctuation or CIDP?
    Hadden RD
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):3. PubMed ID: 19091702
    [No Abstract]   [Full Text] [Related]  

  • 18. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
    van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
    Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is new in 2015 in dysimmune neuropathies?
    Kuntzer T
    Rev Neurol (Paris); 2016 Dec; 172(12):779-784. PubMed ID: 27866728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.